###begin article-title 0
Interleukin-1 Stimulates beta-Cell Necrosis and Release of the Immunological Adjuvant HMGB1
###end article-title 0
###begin p 1
###xml 0 20 0 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests:</bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 1
###begin p 2
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Author Contributions:</bold>
Author Contributions: SAS, ALS, KTC, and JAC designed the study, analyzed the data, and contributed to writing the paper.
###end p 2
###begin article-title 3
Death by Necrosis: The Early Stages of Type 1 Diabetes
###end article-title 3
###begin title 4
Background
###end title 4
###begin p 5
There are at least two phases of beta-cell death during the development of autoimmune diabetes: an initiation event that results in the release of beta-cell-specific antigens, and a second, antigen-driven event in which beta-cell death is mediated by the actions of T lymphocytes. In this report, the mechanisms by which the macrophage-derived cytokine interleukin (IL)-1 induces beta-cell death are examined. IL-1, known to inhibit glucose-induced insulin secretion by stimulating inducible nitric oxide synthase expression and increased production of nitric oxide by beta-cells, also induces beta-cell death.
###end p 5
###begin title 6
Methods and Findings
###end title 6
###begin p 7
###xml 458 463 449 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="boxed-text" rid="pmed-0030017-box001">box 1</xref>
To ascertain the mechanisms of cell death, the effects of IL-1 and known activators of apoptosis on beta-cell viability were examined. While IL-1 stimulates beta-cell DNA damage, this cytokine fails to activate caspase-3 or to induce phosphatidylserine (PS) externalization; however, apoptosis inducers activate caspase-3 and the externalization of PS on beta-cells. In contrast, IL-1 stimulates the release of the immunological adjuvant high mobility group box 1 protein (HMGB1; a biochemical maker of necrosis) in a nitric oxide-dependent manner, while apoptosis inducers fail to stimulate HMGB1 release. The release of HMGB1 by beta-cells treated with IL-1 is not sensitive to caspase-3 inhibition, while inhibition of this caspase attenuates beta-cell death in response to known inducers of apoptosis.
###end p 7
###begin title 8
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
Patient Summary
###end title 8
###begin title 9
Background
###end title 9
###begin p 10
###xml 321 329 <span type="species:ncbi:9606">patients</span>
###xml 627 633 <span type="species:ncbi:9606">humans</span>
Type 1 diabetes (also called autoimmune diabetes or juvenile diabetes) is an autoimmune disease. For unknown reasons, at some point in childhood or adolescence, the body's own immune system starts attacking and destroying the insulin-producing islet cells in the pancreas. Once the majority of islet cells are destroyed, patients can no longer produce insulin to regulate their blood sugar and must depend on strict diets and insulin injections. Scientists are trying to understand the early events during the development of the disease. There are two fundamentally different kinds of cell death in cells of higher animals and humans, called apoptosis and necrosis. Apoptosis (also called programmed cell death) is an organized, clean way in which cells die without spilling their contents and without causing an inflammatory immune response. They are simply gobbled up by other cells that serve as the body's garbage collectors. Necrosis, on the other hand, is a more messy process and one that does activate the immune system and cause local inflammation.
###end p 10
###begin title 11
Why Was This Study Done?
###end title 11
###begin p 12
The scientists who did this study are interested in the early stages of islet cell death. Specifically, they wanted to know whether islet cells during the early events of autoimmune diabetes die via apoptosis or necrosis. Earlier experiments to address this question had yielded no clear-cut results.
###end p 12
###begin title 13
What Did the Researchers Do and Find?
###end title 13
###begin p 14
###xml 189 194 <span type="species:ncbi:9606">human</span>
All the experiments for this study were done in cultured cells in the laboratory. For the most part, the researchers used rodent islet cells, and then they confirmed the crucial finding in human islet cells. They grew the cells under conditions that resembled, to the best of their knowledge, the early stages of diabetes, which caused some of the cells to die. They then did a variety of tests to see whether that cell death was through apoptosis or necrosis, and the results showed that the latter was the case. They also identified some of the key factors involved in promoting and executing the necrosis process.
###end p 14
###begin title 15
What Does This Mean?
###end title 15
###begin p 16
One must always be careful to extrapolate from laboratory results like these. With this caveat, the results suggest that early in the development of diabetes cells die by necrosis, and they point to some of the key factors involved. These are important results that will inform future studies toward the goal of understanding autoimmune diabetes well enough to prevent or stop its development.
###end p 16
###begin title 17
Where Can I Find More Information Online?
###end title 17
###begin p 18
The following Web sites provide information on autoimmune diabetes.
###end p 18
###begin p 19
MedlinePlus pages on type 1 diabetes:
###end p 19
###begin p 20

###end p 20
###begin p 21
Web site of the Juvenile Diabetes Research Foundation:
###end p 21
###begin p 22

###end p 22
###begin p 23
Pages on type 1 diabetes from the Canadian Diabetes Association:
###end p 23
###begin p 24

###end p 24
###begin p 25
Type 1 diabetes pages from the UK National Institute for Health and Clinical Excellence:
###end p 25
###begin p 26

###end p 26
###begin p 27
UK National Diabetes Information Clearinghouse:
###end p 27
###begin p 28

###end p 28
###begin p 29
American Diabetes Association Web site:
###end p 29
###begin p 30

###end p 30
###begin title 31
Conclusions
###end title 31
###begin p 32
These findings indicate that IL-1 induces beta-cell necrosis and support the hypothesis that macrophage-derived cytokines may participate in the initial stages of diabetes development by inducing beta-cell death by a mechanism that promotes antigen release (necrosis) and islet inflammation (HMGB1 release).
###end p 32
###begin p 33
###xml 24 29 <span type="species:ncbi:9606">human</span>
Results from rodent and human cells suggest that necrosis of beta-cells plays a role in the early stages of type 1 diabetes.
###end p 33
###begin title 34
Introduction
###end title 34
###begin p 35
###xml 165 166 162 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b001">1</xref>
###xml 415 416 409 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b002">2</xref>
###xml 417 418 411 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b003">3</xref>
###xml 631 632 622 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b004">4</xref>
###xml 633 634 624 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b005">5</xref>
###xml 955 956 946 947 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b006">6</xref>
###xml 957 958 948 949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b007">7</xref>
###xml 740 745 <span type="species:ncbi:9606">human</span>
Insulin-dependent diabetes is an autoimmune disease characterized by selective destruction of insulin-producing beta-cells found in pancreatic islets of Langerhans [1]. The development of diabetes is characterized initially by insulitis, in which leukocytes migrate to and invade islets. This is followed by overt diabetes, distinguished by insulin insufficiency due to the destruction of a majority of beta-cells [2,3]. Cytokines produced by inflammatory leukocytes and resident and inflammatory macrophages are believed to contribute to the loss of beta-cell function and viability during the development of autoimmune diabetes [4,5]. Interleukin (IL)-1 was identified as the active component of conditioned medium derived from activated human mononuclear cells that causes an inhibition of insulin secretion and the loss of islet cell viability, provided the initial evidence supporting a role for cytokines in the pathogenesis of autoimmune diabetes [6,7].
###end p 35
###begin p 36
###xml 362 363 349 350 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 473 474 460 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b008">8</xref>
###xml 475 476 462 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b009">9</xref>
###xml 573 575 557 559 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 644 645 628 629 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 746 747 730 731 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 749 751 733 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b010">10</xref>
###xml 752 754 736 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b011">11</xref>
###xml 1116 1117 1090 1091 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1119 1121 1093 1095 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b012">12</xref>
###xml 1225 1227 1196 1198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b013">13</xref>
###xml 1228 1230 1199 1201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b014">14</xref>
###xml 1521 1522 1479 1480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b004">4</xref>
###xml 1523 1524 1481 1482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b009">9</xref>
###xml 1525 1527 1483 1485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b015">15</xref>
###xml 1684 1685 1639 1640 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</sup>
###xml 1880 1881 1835 1836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b004">4</xref>
###xml 1882 1883 1837 1838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b008">8</xref>
###xml 1884 1885 1839 1840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b009">9</xref>
###xml 2017 2019 1972 1974 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b016">16</xref>
###xml 2202 2204 2157 2159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b017">17</xref>
###xml 1384 1387 <span type="species:ncbi:10116">rat</span>
###xml 1486 1491 <span type="species:ncbi:10090">mouse</span>
###xml 1507 1512 <span type="species:ncbi:9606">human</span>
###xml 1850 1853 <span type="species:ncbi:10116">rat</span>
###xml 1855 1860 <span type="species:ncbi:10090">mouse</span>
###xml 1866 1871 <span type="species:ncbi:9606">human</span>
###xml 1937 1941 <span type="species:ncbi:10090">mice</span>
###xml 2066 2069 <span type="species:ncbi:10116">rat</span>
The mechanisms by which cytokines impair beta-cell function have been described in detail. Alone or in combination with interferon (IFN)-gamma and tumor necrosis factor (TNF), IL-1 has been shown to stimulate beta-cell expression of inducible nitric oxide synthase (iNOS), and the resulting production of nitric oxide impairs beta-cell oxidation of glucose to CO2, reduces the activity of the Krebs cycle enzyme aconitase, and reduces islet ATP levels by more than 4-fold [8,9]. Importantly, glucose-induced insulin secretion is dependent on beta-cell depolarization and Ca2+ entry, events that are mediated by the inhibition of ATP-sensitive K+ channels due to the accumulation of ATP that is produced by mitochondrial oxidation of glucose to CO2 [10,11]. The targeted disruption of mitochondrial oxidation resulting in the reduction of cellular levels of ATP is one mechanism by which nitric oxide impairs glucose-stimulated insulin secretion. The damaging actions of cytokines on beta-cell function appear to be selective for beta-cells, as IL-1 fails to impair the ability of alpha-cells to oxidize glucose to CO2 [12]. Furthermore, beta-cells are the primary islet-cell source of iNOS in response to cytokine treatment [13,14]. The macrophage-derived cytokine IL-1 is the major regulator of iNOS expression by beta-cells, IL-1 alone is sufficient to stimulate iNOS expression by rat beta-cells, and combinations of IL-1 and IFN-gamma stimulate beta-cell expression of iNOS in most mouse strains and in human islets [4,9,15]. Biochemical and genetic evidence supports a primary role for nitric oxide as the major mediator of cytokine-induced beta-cell damage. The NOS inhibitors NG-monomethyl-L-arginine (NMMA) and aminoguanidine (AG) prevent the inhibitory actions of cytokines on insulin secretion, glucose oxidation, and aconitase activity by rat, mouse, and human islets [4,8,9]. In addition, islets isolated from iNOS-deficient mice are resistant to the inhibitory actions of cytokines on insulin secretion [16], and expression of iNOS under control of the rat insulin promoter results in the development of diabetes in a nitric oxide-dependent manner that occurs in the absence of insulitis [17].
###end p 36
###begin p 37
###xml 600 602 585 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b018">18</xref>
###xml 603 605 588 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b020">20</xref>
###xml 736 738 718 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b021">21</xref>
###xml 937 939 916 918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b019">19</xref>
###xml 940 942 919 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b022">22</xref>
###xml 1157 1159 1130 1132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b018">18</xref>
###xml 1160 1162 1133 1135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b019">19</xref>
###xml 1163 1165 1136 1138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b023">23</xref>
While autoimmune diabetes is characterized by selective destruction of beta-cells, the biochemical mechanisms by which beta-cells are killed are poorly defined. In vitro studies using isolated islets and primary beta-cells have shown that nitric oxide is a primary mediator of impaired beta-cell function in response to cytokine treatment; however, the role of this free radical as a mediator of beta-cell death and the mechanism of cell death has been debated. Much of this debate has centered on whether cytokine-induced islet cell death is apoptotic or necrotic and if nitric oxide is a mediator [18-20]. Early studies by Kolb and coworkers demonstrated that nitric oxide is responsible for IL-1-stimulated DNA damage in beta-cells [21]. More recently, cytokines have been reported to induce beta-cell apoptosis by a process that requires prolonged exposures of 7-9 d and that appears to occur by nitric oxide-independent mechanisms [19,22]. Similar to the inhibitory actions of cytokines on beta-cell function, the macrophage-derived cytokine IL-1 appears to be the primary regulator of cytokine-induced beta-cell death, be it by necrosis or apoptosis [18,19,23].
###end p 37
###begin p 38
###xml 485 487 485 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b024">24</xref>
###xml 488 490 488 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b025">25</xref>
###xml 757 759 757 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b026">26</xref>
In classical terms, apoptosis is defined as programmed cell death by a pathway that removes unwanted cells in the absence of an inflammatory response. It is a highly organized, energy-dependent process that is characterized by caspase activation, the ordered cellular degradation of proteins and organelles, and maintenance of plasma membrane integrity. The final result is noninflammatory phagocytosis of the dying cell, which minimizes leakage of cellular contents and inflammation [24,25]. In contrast, necrosis is an inflammatory process that is characterized by the loss of membrane integrity and the leakage of cellular contents into the extracellular space. It is an unregulated form of cell death that does not require energy or caspase activation [26]. When considering the role of macrophage-derived cytokines such as IL-1 in the context of the initiation of autoimmune diabetes, one would anticipate that this cytokine would kill beta-cells by a mechanism that would promote inflammation. In this report, we compare the effects of IL-1 with known inducers of apoptosis on beta-cell death.
###end p 38
###begin title 39
Methods
###end title 39
###begin title 40
Materials and Animals
###end title 40
###begin p 41
###xml 599 602 596 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N,N</italic>
###xml 15 19 <span type="species:ncbi:10116">rats</span>
###xml 95 98 <span type="species:ncbi:10116">rat</span>
###xml 478 483 <span type="species:ncbi:9606">Human</span>
###xml 1413 1423 <span type="species:ncbi:10141">Guinea pig</span>
###xml 1429 1434 <span type="species:ncbi:9606">human</span>
###xml 1538 1544 <span type="species:ncbi:9793">donkey</span>
###xml 1550 1560 <span type="species:ncbi:10141">guinea pig</span>
###xml 1589 1595 <span type="species:ncbi:9793">donkey</span>
###xml 1601 1607 <span type="species:ncbi:9986">rabbit</span>
###xml 1612 1618 <span type="species:ncbi:9793">donkey</span>
###xml 1624 1629 <span type="species:ncbi:10090">mouse</span>
###xml 1737 1743 <span type="species:ncbi:9986">Rabbit</span>
###xml 1749 1754 <span type="species:ncbi:10090">mouse</span>
Sprague Dawley rats were purchased from Harlan (Indianapolis, Indiana, United States). RINm5F (rat insulinoma) cells were obtained from Washington University Tissue Culture Support Center (St. Louis, Missouri, United States). RPMI 1640 containing L-glutamine, CMRL-1066 tissue culture medium, L-glutamine, penicillin, and streptomycin were obtained from GIBCO-BRL (Grand Island, New York, United States). FCS was obtained from Hyclone Laboratories (Logan, Utah, United States). Human recombinant IL-1beta was obtained from Cistron Biotechnology (Pine Brook, New Jersey, United States). Sodium (Z)-1(N,N-diethylamino) diazen-1-ium-1,2-diolate (DEANO) was obtained from Alexis (San Diego, California, United States). Enhanced chemiluminescence reagent was purchased from Amersham Pharmacia Biotech (Piscataway, New Jersey, United States). MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide), neutral red, DAPI (4',6-diamidino-2-phenylindole dihydrochloride), camptothecin, and staurosporine were obtained from Sigma (St. Louis, Missouri, United States). In Situ Cell Death Detection kit was obtained from Roche (Indianapolis, Indiana, United States). Caspase-3 Fluorometric Assay was obtained from R&D Systems (Minneapolis, Minnesota, United States). Annexin V-FITC Apoptosis Detection kit and the caspase-3 inhibitor Z-DQMD-CHO were obtained from Calbiochem (San Diego, California, United States). Guinea pig anti-human insulin antibody was obtained from Linco Research (St. Louis, Missouri, United States). CY3-conjugated donkey anti-guinea pig antibody and HRP-conjugated donkey anti-rabbit and donkey anti-mouse antisera were obtained from Jackson Immunoresearch Laboratories (West Grove, Pennsylvania, United States). Rabbit anti-mouse HMGB1 antibody was obtained from BD Biosciences Pharmingen (San Diego, California, United States). All other reagents were from commercially available sources.
###end p 41
###begin title 42
Islet Isolation and Cell Culture
###end title 42
###begin p 43
###xml 115 117 115 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b027">27</xref>
###xml 363 364 356 357 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 615 617 608 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b027">27</xref>
###xml 60 64 <span type="species:ncbi:10116">rats</span>
###xml 230 234 <span type="species:ncbi:9913">calf</span>
###xml 466 469 <span type="species:ncbi:10116">rat</span>
Islets were isolated from 250- to 300-g male Sprague Dawley rats by collagenase digestion as previously described [27]. Islets were cultured overnight in complete CMRL-1066 (containing 2 mM L-glutamine, 10% heat-inactivated fetal calf serum, 100 U/ml penicillin, 100 mug/ml streptomycin, and 5.5 mM glucose) at 37 degreesC under an atmosphere of 95% air and 5% CO2 prior to experimentation. For annexin V and terminal nick-end labeling (TUNEL) assays of cell death, rat islets were treated with IL-1 for the indicated times followed by dispersion into individual cells by trypsin digestion as previously described [27]. RINm5F cells were grown in RPMI 1640 tissue culture medium to a density of approximately75% prior to experimentation. The cells were then removed from growth flasks by treatment with 0.05% trypsin and 0.02% EDTA for 5 min at 37 degreesC, washed two times with complete CMRL-1066 media, and plated in CMRL-1066 at the indicated density.
###end p 43
###begin p 44
###xml 301 302 295 296 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 169 174 <span type="species:ncbi:9606">human</span>
Human islets were obtained from the Islet Cell Resource Center at Washington University School of Medicine (St. Louis, Missouri, United States). Before experiments, the human islets were cultured for 48 h at 37 degreesC in complete CMRL-1066 tissue culture medium in an atmosphere of 95% air and 5% CO2.
###end p 44
###begin title 45
Cell Death Assays
###end title 45
###begin p 46
###xml 172 174 172 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b028">28</xref>
###xml 232 233 232 233 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 209 212 <span type="species:ncbi:10116">rat</span>
Cell viability was examined using the MTT assay and neutral red uptake. The MTT assay is based on the ability of viable cells to reduce MTT to insoluble formazan crystals [28]. For this assay, RINm5F cells or rat islet cells (1 x 105 cells in 200 mul of complete CMRL-1066) were washed with tissue culture medium following treatments, and MTT was added at a final concentration of 0.5 mg/ml. Following an incubation for 3 h at 37 degreesC, the supernatants were removed and discarded, and the cells were lysed with acid-isopropanol (100 mul of 0.04 N HCl in isopropanol) and mixed thoroughly to dissolve the crystals for 5 min at room temperature. The optical density of this product was determined at a wavelength of 570 nm.
###end p 46
###begin p 47
###xml 100 102 100 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b029">29</xref>
###xml 170 171 170 171 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 572 573 564 565 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 147 150 <span type="species:ncbi:10116">rat</span>
Cell viability was also evaluated by examining the accumulation of neutral red dye in viable cells [29]. For this assay, RINm5F cells or dispersed rat islet cells (1 x 105 cells in 200 mul of complete CMRL-1066) were cultured for 24 or 48 h with the indicated concentrations of IL-1, camptothecin, or staurosporine; the culture supernatants were removed and discarded; and the cells were incubated in fresh medium containing 50 mug/ml neutral red at 37 degreesC. Following a 2-h incubation, the supernatant was removed, the cells were washed with a 1% formaldehyde-1% CaCl2 solution, and the neutral red dye was extracted in 100 mul of a 50% ethanol-1% acetic acid lysing solution. The accumulation of neutral red dye in the lysing solution was measured at a wavelength of 570 nm. Cell viability using both the MTT and neutral red assays is expressed as the percent of dead cells.
###end p 47
###begin title 48
Annexin V-FITC Staining
###end title 48
###begin p 49
###xml 39 40 39 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 380 382 379 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b030">30</xref>
###xml 16 19 <span type="species:ncbi:10116">rat</span>
RINm5F cells or rat islet cells (1 x 105 cells in 200 mul of complete CMRL-1066) were treated as indicated in the figure legends. Cells were removed from plates by cell scraping (RINm5F) or washing (islet cells). Externalization of phosphatidylserine (PS) was evaluated by annexin V staining according to manufacturer's instructions (Calbiochem) and quantified by flow cytometry [30].
###end p 49
###begin title 50
TUNEL Staining/Immunohistochemistry
###end title 50
###begin p 51
###xml 39 40 39 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 605 607 603 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b031">31</xref>
###xml 16 19 <span type="species:ncbi:10116">rat</span>
###xml 519 522 <span type="species:ncbi:10116">rat</span>
RINm5F cells or rat islet cells (4 x 105 cells in 400 mul of complete CMRL-1066) were treated as indicated in the figure legends. The cells were removed from plates and centrifuged onto glass slides. DNA damage was quantified by TUNEL staining according to the manufacturer's instructions using the In Situ Cell Death Detection Kit, Fluorescein (Roche). Cells containing DNA damage were colocalized with DAPI by incubating cells with DAPI (5 mug/ml) for 15 min followed by three washes with PBS (pH 7.4). DNA damage in rat islet cells was colocalized with insulin-containing cells as outlined previously [31].
###end p 51
###begin title 52
Caspase-3 Activity
###end title 52
###begin p 53
###xml 39 40 39 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 16 19 <span type="species:ncbi:10116">rat</span>
RINm5F cells or rat islet cells (4 x 105 cells in 400 mul of complete CMRL-1066) were treated as indicated in the figure legends. Cells were isolated and lysed, and capase-3 activity in the cell lysate was determined according to the manufacturer's instructions (Caspase-3 Fluorometric Assay Kit, R&D Systems). Caspase-3 activity was normalized to protein content and is presented as the fold-increase over the level of activity measured in the untreated control.
###end p 53
###begin title 54
Western Blot Analysis
###end title 54
###begin p 55
###xml 222 224 222 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b032">32</xref>
###xml 47 50 <span type="species:ncbi:10116">rat</span>
###xml 380 386 <span type="species:ncbi:9986">rabbit</span>
###xml 392 397 <span type="species:ncbi:10090">mouse</span>
###xml 433 439 <span type="species:ncbi:9793">donkey</span>
###xml 445 451 <span type="species:ncbi:9986">rabbit</span>
Protein lysates prepared from RINm5F cells and rat islets were separated by SDS-PAGE and then transferred to nitrocellulose membranes (Amersham Pharmacia Biotech) under semidry transfer conditions as previously described [32]. Antigen was detected by enhanced chemiluminescence according to the manufacturer's specifications (Amersham Pharmacia Biotech). Antibody dilutions were: rabbit anti-mouse HMGB1, 1:1,000; and HRP-conjugated donkey anti-rabbit, 1:7,000.
###end p 55
###begin title 56
Nitrite Determination
###end title 56
###begin p 57
###xml 105 107 103 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b033">33</xref>
Nitrite production was determined by mixing 50 mul of cell culture medium with 50 mul of Griess reagent [33]. The absorbance at 540 nm was measured, and nitrite concentrations were calculated from a sodium nitrite standard curve.
###end p 57
###begin title 58
Statistics
###end title 58
###begin p 59
###xml 110 111 110 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Statistical comparisons were made between groups using one-way ANOVA. Significant differences between groups (p < 0.05) were determined by Newman-Keuls post-hoc analysis.
###end p 59
###begin title 60
Results
###end title 60
###begin title 61
Nitric Oxide Mediates Cytokine-Induced Islet Cell Death
###end title 61
###begin p 62
###xml 229 230 226 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b008">8</xref>
###xml 231 233 228 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b018">18</xref>
###xml 234 236 231 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b019">19</xref>
###xml 454 456 447 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b034">34</xref>
###xml 457 459 450 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b036">36</xref>
###xml 654 656 641 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b019">19</xref>
###xml 657 659 644 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b022">22</xref>
###xml 902 910 871 879 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030017-g001">Figure 1</xref>
###xml 1049 1057 1006 1014 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030017-g001">Figure 1</xref>
###xml 1149 1157 1094 1102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030017-g001">Figure 1</xref>
###xml 1247 1255 1180 1188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030017-g001">Figure 1</xref>
###xml 1312 1320 1245 1253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030017-g001">Figure 1</xref>
###xml 1384 1392 1317 1325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030017-g001">Figure 1</xref>
###xml 1529 1537 1450 1458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030017-g001">Figure 1</xref>
###xml 1627 1635 1548 1556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030017-g001">Figure 1</xref>
While it is clear that the inhibitory actions of cytokines such as IL-1 on glucose-stimulated insulin secretion are mediated by beta-cell production of nitric oxide, the role of nitric oxide in islet cell death has been debated [8,18,19]. Short exposures (24-48 h) of islets and insulinoma cell lines to IL-1 alone, or in combination with IFN-gamma, and TNF cause islet cell DNA damage and reduced oxidative capacity in a nitric oxide-dependent fashion [34-36]; however, prolonged exposures (7-9 d) of islets or purified beta-cells with IL-1 or cytokine combinations have been reported to induce beta-cell apoptosis in a nitric oxide-independent manner [19,22]. To investigate the mechanisms of cytokine-induced beta-cell death, we initially examined whether IL-1 reduces beta-cell viability using the MTT assay. Following a 24-h incubation with IL-1, death of RINm5F cells increased approximately20% (Figure 1A), and this cell death correlated with a approximately10-fold increase in production of nitrite, an oxidative metabolite of nitric oxide (Figure 1B). Following a 48-h incubation with IL-1, RINm5F cell death increased to approximately40% (Figure 1A), and cell death correlated with a approximately20-fold increase in nitrite production (Figure 1B). The NOS inhibitor NMMA prevented nitrite production (Figure 1B) and significantly attenuated IL-1-induced RINm5F cell death (Figure 1A). Similar to its effect in RINm5F cells, IL-1 induced the death of approximately25% of islet cells following 24- and 48-h incubations (Figure 1C). IL-1-induced islet cell death correlated with an increase in nitric oxide production (Figure 1D), and NMMA attenuated both islet cell death and nitric oxide production. These findings suggest that IL-1 induces islet and RINm5F cell death, that cell death correlates with the production of nitric oxide, and that cell death is attenuated by the inhibition of NOS.
###end p 62
###begin p 63
###xml 343 344 340 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b009">9</xref>
###xml 467 475 464 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030017-g001">Figure 1</xref>
###xml 877 879 862 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b037">37</xref>
###xml 898 906 883 891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030017-g001">Figure 1</xref>
###xml 1240 1242 1213 1215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b038">38</xref>
###xml 1330 1338 1291 1299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030017-g001">Figure 1</xref>
To examine whether nitric oxide can directly modulate cell viability, the effects of exogenously supplied nitric oxide on RINm5F cell viability were examined. RINm5F cells were chosen for these studies because they represent a homogenous population of beta-cells, and the effects of cytokines on these cells have been characterized in detail [9]. Treatment of RINm5F cells for 24 h with the nitric oxide donor compound DEANO resulted in a 25% increase in cell death (Figure 1E). Following a 48-h exposure to DEANO, the level of death was not further increased, a finding that is likely due to the rapid decomposition of DEANO (which has a half-life of approximately2 min under these conditions). The effects of DEANO were compared to known inducers of apoptosis. The topoisomerase inhibitor camptothecin is a classical inducer of apoptosis in rapidly proliferating cell lines [37] and, as shown in Figure 1E, induces the death of approximately40% and 75% of RINm5F cells following 24- and 48-h incubations, respectively. Camptothecin is not an effective inducer of islet cell death (most likely due to the quiescent nature of these cells [unpublished data]); however, the kinase inhibitor staurosporine, another known inducer of apoptosis [38], stimulated the death of approximately40% of islet cells following a 24-h incubation (Figure 1F).
###end p 63
###begin p 64
###xml 130 138 127 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030017-g002">Figure 2</xref>
###xml 274 276 271 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b029">29</xref>
###xml 333 341 330 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030017-g001">Figure 1</xref>
###xml 505 513 490 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030017-g002">Figure 2</xref>
###xml 684 692 657 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030017-g002">Figure 2</xref>
A second assay of cell viability, neutral red uptake, was used to confirm the observations that cytokines induce beta-cell death (Figure 2). This assay is based on the ability of viable cells to accumulate neutral red dye, while nonviable cells fail to accumulate this dye [29]. Similar to the results presented for the MTT assay in Figure 1, IL-1 reduced RINm5F cell viability by approximately20%-25% following 24- or 48-h incubations, and cell death in response to this cytokine was attenuated by NMMA (Figure 2A). The apoptosis inducer camptothecin also reduced RINm5F cell viability by approximately60%-80% following 24- and 48-h incubations, as determined by neutral red uptake (Figure 2B). These findings provide evidence, in two different assays of cell death, that IL-1 reduces beta-cell viability and that the loss of viability is mediated, in part, by the production of nitric oxide.
###end p 64
###begin title 65
Morphological Analysis of IL-1-Induced beta-Cell Death
###end title 65
###begin p 66
###xml 275 283 275 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030017-g003">Figure 3</xref>
###xml 415 423 415 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030017-g003">Figure 3</xref>
###xml 657 665 657 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030017-g003">Figure 3</xref>
###xml 975 983 975 983 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030017-g003">Figure 3</xref>
While performing the cell viability experiments, clear morphological differences were observed for RINm5F cells treated with IL-1 as compared to the apoptosis inducer camptothecin. Control, untreated RINm5F cells grew as a flat monolayer of cells with distinct cell borders (Figure 3A). Treatment with IL-1 resulted in morphological changes that included cell swelling and the appearance of holes in the cytoplasm (Figure 3B), changes that are consistent with a necrotic form of cell death. Nitric oxide appears to be responsible for the morphological changes induced by IL-1, as NMMA attenuated RINm5F cell swelling and the formation of cytoplasmic holes (Figure 3C). The morphological changes in RINm5F cells undergoing apoptosis were strikingly different from the alterations induced by IL-1. RINm5F cells that underwent apoptosis following a 24-h treatment with camptothecin were severely shrunken and contained compacted nuclei, consistent with an apoptotic morphology (Figure 3D). This morphological analysis of the effects of IL-1 on RINm5F cell viability suggests that cytokine-induced beta-cell death is not caused by classical apoptotic mechanisms and may occur by necrotic mechanisms.
###end p 66
###begin title 67
IL-1 Stimulates beta-cell DNA Damage in a Nitric Oxide-Dependent Manner
###end title 67
###begin p 68
###xml 382 390 382 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030017-g004">Figure 4</xref>
###xml 465 473 465 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030017-g004">Figure 4</xref>
###xml 588 596 588 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030017-g005">Figure 5</xref>
###xml 705 713 693 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030017-g004">Figure 4</xref>
###xml 821 829 797 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030017-g004">Figure 4</xref>
###xml 996 1004 960 968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030017-g004">Figure 4</xref>
###xml 1010 1011 974 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030017-g004">4</xref>
###xml 1489 1497 1453 1461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030017-g004">Figure 4</xref>
###xml 1503 1504 1467 1468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030017-g004">4</xref>
###xml 1659 1667 1611 1619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030017-g004">Figure 4</xref>
###xml 239 242 <span type="species:ncbi:10116">rat</span>
The TUNEL assay is commonly used to detect DNA damage in cells, and the results have frequently been used as evidence to support an apoptotic pathway of cell death. Using the TUNEL assay, the effects of IL-1 on the integrity of RINm5F and rat islet cell DNA were examined. In this assay, DNA strand breaks were detected by the incorporation of fluorescein dUTP (green fluorescence, Figure 4), and nuclei were visualized by co-staining with DAPI (blue fluorescence, Figure 4) or colocalized with insulin-containing islet cells (using a CY3-conjugated secondary antibody; red fluorescence, Figure 5). Treatment of RINm5F cells for 24 h with IL-1 resulted in DNA damage in approximately50% of the cells (see Figure 4B), and the level of DNA damage increased to approximately65% of the cells following a 48-h incubation (see Figure 4C). Importantly, IL-1-induced DNA damage was attenuated by NMMA to levels similar to those observed in untreated control cells (approximately5%-8% TUNEL-positive; see Figure 4E and 4F). Representative fluorescent micrographs indicate that the morphology of TUNEL-positive RINm5F cells following treatment with IL-1 is significantly different from the morphology of cells treated with the apoptosis inducer camptothecin. While TUNEL staining in most RINm5F cells treated with IL-1 appeared uniform throughout the nuclei and colocalized with DAPI staining, there were a number of RINm5F cells in which the TUNEL staining appears to spill out of the nucleus (see Figure 4B and 4C, white arrows), indicating a loss of nuclear membrane integrity. Camptothecin stimulated DNA damage in approximately60% of the RINm5F cells, as shown in Figure 4D (white arrow), and the pattern of TUNEL and DAPI staining was distinctly different from that observed following IL-1 treatment. Camptothecin-induced TUNEL and DAPI staining appears more intense and punctate, indicating that chromatin condensation has occurred.
###end p 68
###begin p 69
###xml 275 283 260 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030017-g005">Figure 5</xref>
###xml 334 342 319 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030017-g005">Figure 5</xref>
###xml 780 788 753 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030017-g005">Figure 5</xref>
###xml 821 829 794 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030017-g004">Figure 4</xref>
###xml 937 945 910 918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030017-g005">Figure 5</xref>
###xml 1059 1067 1032 1040 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030017-g005">Figure 5</xref>
###xml 38 41 <span type="species:ncbi:10116">rat</span>
###xml 431 434 <span type="species:ncbi:10116">rat</span>
###xml 575 578 <span type="species:ncbi:10116">rat</span>
Similar to RINm5F cells, treatment of rat islets for 48 h with IL-1 resulted in DNA damage in approximately50% of islet cells, and over 95% of this DNA damage was found in beta-cells, as determined by immunolocalization of TUNEL-positive cells with insulin-containing cells (Figure 5B). IL-1-induced DNA damage was prevented by NMMA (Figure 5D), indicating that nitric oxide is primarily responsible for the DNA damage observed in rat islet cells treated with IL-1. IL-1-induced DNA damage was compared with damage caused by the apoptosis inducer staurosporine. Treatment of rat islets for 48 h with staurosporine resulted in TUNEL-positive staining in approximately50% of islet cells, and this DNA damage was observed in both insulin-containing and non-insulin-containing cells (Figure 5C). Similar to RINm5F cells (see Figure 4), the morphology of TUNEL staining in the IL-1-treated islet cells appears uniform throughout the nucleus (Figure 5B, white arrows). In contrast, staurosporine-induced TUNEL staining in islet cells was more intense and punctate (Figure 5C, white arrows). Taken together, these findings suggest that IL-1 stimulates DNA damage in beta-cells, and that nitric oxide is a primary mediator of this damage. In addition, these findings indicate that DNA damage induced by IL-1 results in morphological changes in beta-cells that are markedly different from the DNA damage observed in beta-cells undergoing staurosporine-induced apoptosis.
###end p 69
###begin title 70
###xml 52 55 <span type="species:ncbi:10116">Rat</span>
IL-1 Fails to Activate Caspase-3 in RINm5F Cells or Rat Islets
###end title 70
###begin p 71
###xml 344 346 344 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b039">39</xref>
###xml 347 349 347 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b040">40</xref>
###xml 415 423 415 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030017-g006">Figure 6</xref>
###xml 441 449 441 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030017-g006">Figure 6</xref>
###xml 544 546 544 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b041">41</xref>
###xml 547 549 547 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b043">43</xref>
###xml 912 920 900 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030017-g006">Figure 6</xref>
###xml 1021 1029 997 1005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030017-g006">Figure 6</xref>
###xml 64 67 <span type="species:ncbi:10116">rat</span>
###xml 429 432 <span type="species:ncbi:10116">rat</span>
###xml 740 743 <span type="species:ncbi:10116">rat</span>
###xml 1009 1012 <span type="species:ncbi:10116">rat</span>
To directly examine whether IL-1 induces classical apoptosis in rat islets or RINm5F cells, the effects of this cytokine on the activation of caspase-3 were examined. We decided to examine caspase-3 because it is an executioner caspase that is a downstream target of caspases involved in both the intrinsic and extrinsic pathways of apoptosis [39,40]. IL-1 failed to stimulate caspase-3 activation in RINm5F cells (Figure 6A) or rat islets (Figure 6B) treated for either 24 or 48 h. Since nitric oxide is a known inhibitor of caspase activity [41-43], the effects of IL-1 alone and in combination with NMMA on caspase-3 activity were examined. In the presence of NMMA, IL-1 still failed to stimulate caspase-3 activation in RINm5F cells or rat islets. In contrast to the lack of caspase-3 activation in response to IL-1, camptothecin induced a approximately9-fold increase in caspase-3 activity in RINm5F cells (Figure 6A), and staurosporine stimulated a approximately5-fold increase in caspase-3 activity in rat islets (Figure 6B).
###end p 71
###begin title 72
###xml 58 61 <span type="species:ncbi:10116">Rat</span>
Effects of IL-1 on Annexin V Staining in RINm5F Cells and Rat Islets
###end title 72
###begin p 73
###xml 250 252 250 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b030">30</xref>
###xml 346 354 346 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030017-g007">Figure 7</xref>
###xml 377 385 377 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030017-g007">Figure 7</xref>
###xml 360 363 <span type="species:ncbi:10116">rat</span>
###xml 543 546 <span type="species:ncbi:10116">rat</span>
###xml 682 685 <span type="species:ncbi:10116">rat</span>
The externalization of PS on the outer membrane surface of cells is a hallmark of cells undergoing early or intermediate stages of apoptosis that can be quantified by flow cytometry using the calcium-dependent phospholipid-binding protein annexin V [30]. Using this assay, we show that IL-1 fails to stimulate PS externalization on RINm5F cells (Figure 7A) or rat islet cells (Figure 7B). In contrast, approximately55% of RINm5F cells stained positive for annexin V following a 24 or 48-h incubation with camptothecin, and approximately15% of rat islet cells stained positive for annexin V following a 24- or 48-h incubation with staurosporine. The absence of annexin V staining on rat islet cells and RINm5F cells treated with IL-1 is consistent with the lack of caspase-3 activation, and suggests that, while IL-1 stimulates beta-cell death, it does not appear to occur by classical apoptotic mechanisms.
###end p 73
###begin title 74
Biochemical Evidence that IL-1 Stimulates beta-Cell Necrosis
###end title 74
###begin p 75
###xml 96 98 96 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b026">26</xref>
###xml 99 101 99 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b044">44</xref>
###xml 102 104 102 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b046">46</xref>
###xml 194 196 194 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b045">45</xref>
###xml 445 453 442 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030017-g008">Figure 8</xref>
###xml 707 715 704 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030017-g008">Figure 8</xref>
###xml 970 978 961 969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030017-g008">Figure 8</xref>
###xml 996 1004 987 995 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030017-g008">Figure 8</xref>
###xml 1219 1228 1210 1219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030017-g008">Figures 8</xref>
###xml 1234 1235 1225 1226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030017-g008">8</xref>
###xml 695 698 <span type="species:ncbi:10116">rat</span>
###xml 770 773 <span type="species:ncbi:10116">rat</span>
###xml 984 987 <span type="species:ncbi:10116">rat</span>
###xml 1315 1318 <span type="species:ncbi:10116">rat</span>
###xml 1386 1389 <span type="species:ncbi:10116">rat</span>
HMGB1 is a chromatin-binding protein that is selectively released by cells undergoing necrosis [26,44-46]. It is not released from cells undergoing apoptosis, as it is sequestered by chromatin [45]. To determine whether IL-1 stimulates beta-cell necrosis, RINm5F cells were treated for 24 or 48 h in the presence or absence of NMMA, and the supernatants were isolated and examined by Western blot analysis for the presence of HMGB1. As shown in Figure 8A, IL-1 stimulates the release of low levels of HMGB1 by RINm5F cells, which is first apparent following a 24-h incubation, with higher levels released following a 48-h incubation. In a similar manner, IL-1 stimulated the release of HMGB1 by rat islets (Figure 8B). NMMA attenuates IL-1-induced HMGB1 release by both rat islets and RINm5F cells, indicating that nitric oxide is a mediator of beta-cell necrosis. To confirm that nitric oxide induces beta-cell necrosis, we show that a 24-h incubation of RINm5F cells (Figure 8C) or rat islets (Figure 8D) with the nitric oxide donor DEANO results in HMGB1 release. In contrast, barely detectable levels of HMGB1 were released by RINm5F cells treated with camptothecin or islets incubated with staurosporine for 24 h (Figures 8C and 8D). As a control, inactivated DEANO failed to stimulate HMGB1 release by either rat islets or RINm5F cells (unpublished data). The release of HMGB1 by rat islets and RINm5F cells provides biochemical evidence that IL-1 stimulates beta-cell death by necrotic mechanisms.
###end p 75
###begin title 76
Effect of Caspase-3 Inhibition on Cytokine-Induced beta-Cell Death
###end title 76
###begin p 77
###xml 294 302 288 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030017-g009">Figure 9</xref>
###xml 326 334 320 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030017-g009">Figure 9</xref>
###xml 507 515 501 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030017-g009">Figure 9</xref>
###xml 667 675 661 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030017-g009">Figure 9</xref>
###xml 721 729 715 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030017-g009">Figure 9</xref>
To further explore the mechanisms of beta-cell death, the effects of caspase-3 inhibition on beta-cell death in response to apoptosis inducers and IL-1 were examined. As expected, the caspase-3 inhibitor Z-DQMD-CHO attenuated camptothecin-induced RINm5F cell death, as determined by MTT assay (Figure 9A), annexin V staining (Figure 9B), and caspase-3 activation (unpublished data). In contrast, inhibition of caspase-3 failed to attenuate IL-1-induced RINm5F cell death following a 24- or 48-h incubation (Figure 9C). Furthermore, caspase-3 inhibition failed to prevent RINm5F cell HMGB1 release induced by the exogenous addition of nitric oxide by the donor DEANO (Figure 9D), or following a 48-h incubation with IL-1 (Figure 9E). These findings demonstrate that beta-cell death in response to IL-1 treatment does not require the activation of caspase-3, an executioner caspase, and that caspase-3 inhibition does not prevent beta-cell necrosis in response to IL-1 treatment or exposure to exogenous nitric oxide, as assessed by the release of HMGB1.
###end p 77
###begin title 78
###xml 39 44 <span type="species:ncbi:9606">Human</span>
Cytokines Stimulate HMGB1 Release from Human Islets in a Nitric Oxide-Dependent Manner
###end title 78
###begin p 79
###xml 372 374 368 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b047">47</xref>
###xml 375 377 371 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b049">49</xref>
###xml 679 688 659 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030017-g010">Figure 10</xref>
###xml 930 939 910 919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030017-g010">Figure 10</xref>
###xml 38 41 <span type="species:ncbi:10116">rat</span>
###xml 195 200 <span type="species:ncbi:9606">human</span>
###xml 348 353 <span type="species:ncbi:9606">human</span>
###xml 422 427 <span type="species:ncbi:9606">human</span>
###xml 493 498 <span type="species:ncbi:9606">human</span>
###xml 574 579 <span type="species:ncbi:9606">human</span>
###xml 833 838 <span type="species:ncbi:9606">human</span>
###xml 1121 1126 <span type="species:ncbi:9606">human</span>
###xml 1365 1370 <span type="species:ncbi:9606">human</span>
###xml 1501 1506 <span type="species:ncbi:9606">human</span>
###xml 1598 1603 <span type="species:ncbi:9606">human</span>
###xml 1679 1682 <span type="species:ncbi:10116">rat</span>
###xml 1830 1835 <span type="species:ncbi:9606">human</span>
In contrast to the effects of IL-1 on rat islets, a combination of cytokines (IL-1, TNF, and IFN-gamma) is required to stimulate nitric oxide synthase expression and nitric oxide production from human islets. Previous studies have shown that, individually, these cytokines fail to stimulate iNOS expression or nitric oxide production, or to induce human islet cell death [47-49]. To examine whether nitric oxide modulates human islet viability, we examined the effects of a 48-h incubation of human islets with IL-1, IFN-gamma, and TNF on the release of HMGB1. Treatment of human islets with this cytokine mixture stimulated a approximately7 fold increase in nitrite production (Figure 10A), and nitric oxide production correlated with high levels of iNOS expression (unpublished observation). Importantly, under conditions in which human islets produce nitric oxide, HMGB1 accumulated in the supernatant of these islet cultures (Figure 10B). HMGB1 release appears to be dependent on the production of nitric oxide, as the iNOS selective inhibitor AG attenuated the production of nitric oxide and the release of HMGB1 by human islets. The apoptosis inducer staurosporine failed to stimulate the production of nitric oxide or release of HMGB1. Alone, neither IL-1, TNF, nor IFN-gamma stimulated nitric oxide production, iNOS expression, or the release of HMGB1 from human islets following a 24- or 48-h incubation (unpublished data), providing evidence that the increased production of nitric oxide by human islets in response to the combination of cytokines is required for the release of HMGB1 by human islets. Overall, these findings are consistent with the effects of IL-1 on rat islets and RINm5F cells, in that they provide direct evidence that nitric oxide mediates the release of HMGB1, a marker of necrotic cell death, by human islets in response to cytokine treatment.
###end p 79
###begin title 80
Discussion
###end title 80
###begin p 81
###xml 361 362 358 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b002">2</xref>
###xml 363 364 360 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b003">3</xref>
###xml 365 367 362 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b050">50</xref>
###xml 614 615 605 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b003">3</xref>
###xml 616 618 607 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b051">51</xref>
###xml 962 963 947 948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b003">3</xref>
###xml 964 966 949 951 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b051">51</xref>
###xml 1163 1165 1145 1147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b052">52</xref>
Autoimmune diabetes is characterized by an inability to regulate blood glucose levels due to the autoimmune destruction of insulin-producing pancreatic beta-cells. The development of autoimmune diabetes is a T cell-dependent process, as they represent a major cellular constituent found in insulitis, and it is possible to prevent diabetes by T cell depletion [2,3,50]. While T cells are responsible for killing the majority of beta-cells during the development of diabetes, relatively little is known concerning the events that initiate this autoimmune response directed against beta-cells. Mathis and coworkers [3,51] have recently proposed that beta-cell death during normal physiological islet remodeling, which peaks at 14-17 d after birth, may supply beta-cell antigens that can then be engulfed by dendritic cells. These antigen-presenting cells (APCs) then ferry the antigen to pancreatic lymph nodes, where they may activate naive diabetogenic T cells [3,51]. Although the mechanisms of beta-cell death during islet remodeling are likely apoptotic, it is possible to mount a T cell response by antigens produced by cells undergoing apoptotic cell death [52].
###end p 81
###begin p 82
###xml 93 95 93 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b051">51</xref>
###xml 229 231 229 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b053">53</xref>
###xml 232 234 232 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b054">54</xref>
###xml 672 674 666 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b055">55</xref>
###xml 675 677 669 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b056">56</xref>
###xml 1187 1188 1169 1170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b004">4</xref>
###xml 1189 1190 1171 1172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b005">5</xref>
###xml 1191 1193 1173 1175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b057">57</xref>
###xml 1358 1360 1340 1342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b058">58</xref>
###xml 1361 1363 1343 1345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b059">59</xref>
###xml 1432 1434 1414 1416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b060">60</xref>
###xml 1488 1490 1470 1472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b061">61</xref>
###xml 1674 1676 1653 1655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b013">13</xref>
###xml 1677 1679 1656 1658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b014">14</xref>
###xml 1680 1682 1659 1661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b062">62</xref>
###xml 86 91 <span type="species:ncbi:10090">mouse</span>
###xml 1482 1486 <span type="species:ncbi:10116">rats</span>
###xml 1618 1623 <span type="species:ncbi:9606">human</span>
While experimental evidence supports this model for initiation of diabetes in the NOD mouse [51], this model does not take into account the low concordance rate and variable time of onset of diabetes observed in identical twins [53,54]. Specifically, if beta-cell death during normal physiological islet remodeling supplies antigens that activate naive diabetogenic T cells, one would have to assume that the extent/efficiency of beta-cell death and/or antigen processing and presentation to naive T cells may be highly variable in individuals with an identical genetic makeup. An alternative hypothesis to explain the initiation of autoimmune diabetes, proposed by Lacy [55,56], suggests that intraislet macrophage activation and local release of macrophage-derived inflammatory mediators initiates beta-cell death, antigen release, and autoimmunity directed against beta-cells. The initiating event leading to intraislet macrophage activation may be viral, bacterial, or chemical in origin. It is well known that viral or bacterial infection stimulates macrophage production of IL-1 and TNF, and these cytokines have been shown to impair beta-cell function and induce beta-cell death [4,5,57]. In support of this model, previous studies have shown that feeding rodents a diet deficient in essential free fatty acids, known to deplete resident macrophages [58,59], attenuates diabetes induced by the chemical toxin streptozotocin [60] and the natural progression of diabetes in BB rats [61]. In addition, a number of studies have shown that the local release of IL-1 by activated intraislet macrophages in rodent and human islets leads to beta-cell dysfunction and damage [13,14,62].
###end p 82
###begin p 83
###xml 294 305 288 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030017-g001">Figures 1&#8211;3</xref>
###xml 1460 1462 1436 1438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b039">39</xref>
###xml 1463 1465 1439 1441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b040">40</xref>
###xml 2099 2101 2069 2071 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b041">41</xref>
###xml 2102 2104 2072 2074 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b043">43</xref>
###xml 1819 1822 <span type="species:ncbi:10116">rat</span>
In this report we have evaluated the cellular mechanisms by which the macrophage-derived cytokine IL-1 kills beta-cells. Using three different methods to evaluate cell viability, MTT oxidation, neutral red uptake, and TUNEL staining (DNA damage), we show that IL-1 induces beta-cell death (see Figures 1-3). Nitric oxide appears to be one mediator of beta-cell death, as NOS inhibition attenuated cell death in response to IL-1, and nitric oxide, supplied exogenously using donor compounds, reduced beta-cell viability. The mechanism by which IL-1 stimulates beta-cell death is both morphologically and biochemically different from known inducers of apoptosis. Morphologically, IL-1-induced beta-cell death is characterized by cell swelling and diffuse TUNEL staining-changes indicative of the loss of membrane integrity, or necrosis. In response to inducers of apoptosis, the morphology of dying beta-cells differs drastically from the effects of IL-1. Apoptosis induction results in cell shrinkage and tight, punctate TUNEL staining, consistent with the form of cell death that we have observed with known inducers of apoptosis. To investigate biochemical mechanisms responsible for beta-cell death, we evaluated the effects of IL-1 on caspase-3 activation and PS externalization (annexin staining). Caspase-3 activity was chosen because it the executioner caspase activated by initiator caspases involved in both extrinsic and intrinsic apoptotic pathways [39,40]. While many reports have suggested that IL-1 induces beta-cell death by apoptosis, we show that IL-1 fails to activate caspase-3 or to stimulate annexin V staining in islets or RINm5F cells. In contrast, known apoptosis inducers stimulated 6- to 9-fold increases in caspase-3 activity and significantly increased annexin V staining on RINm5F cells and rat islet cells. The lack of RINm5F cell and islet caspase activity following treatment with IL-1 is not surprising, as IL-1 stimulates beta-cell production of nitric oxide, and nitric oxide has been shown to inhibit caspase activity by S-nitrosation of the active site cysteine [41,43].
###end p 83
###begin p 84
###xml 194 202 191 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030017-g003">Figure 3</xref>
###xml 276 285 273 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030017-g004">Figures 4</xref>
###xml 290 291 287 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030017-g005">5</xref>
###xml 696 698 687 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b063">63</xref>
###xml 853 855 844 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b026">26</xref>
###xml 856 858 847 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b044">44</xref>
###xml 859 861 850 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b046">46</xref>
###xml 255 258 <span type="species:ncbi:10116">rat</span>
###xml 944 947 <span type="species:ncbi:10116">rat</span>
###xml 1290 1293 <span type="species:ncbi:10116">rat</span>
Since these findings suggest that the macrophage-derived cytokine IL-1 does not induce apoptosis, we sought to identify whether IL-1 kills beta-cells by necrosis. The morphological changes (see Figure 3) and the diffuse TUNEL staining in RINm5F cells and rat islet cells (see Figures 4 and 5) induced by IL-1 treatment are consistent with a necrotic type of cell death. To provide biochemical evidence in support of IL-1-induced beta-cell necrosis, the effects of this cytokine on the release of HMGB1 from beta-cells was examined. HMGB1 is a chromatin-binding protein that functions to distort the double helix, allowing proper physical interactions between transcription factors and chromatin [63]. Recent studies have shown that HMGB1 is released from cells dying by necrosis, but it remains tightly bound to chromatin in cells undergoing apoptosis [26,44-46]. In this study, we show that IL-1 stimulates HMGB1 release from RINm5F cells and rat islets in a nitric oxide-dependent manner, and that HMGB1 release is not affected by the inhibition of caspase activity. These findings suggest that IL-1-induced HMGB1 release is mediated, at least in part, by nitric oxide, a conclusion further supported by the ability of nitric oxide to directly stimulate HMGB1 release by RINm5F cells and rat islets. Importantly, under conditions in which RINm5F cells or islets have been forced to undergo apoptosis, HMGB1 was not released. Overall, this morphological and biochemical evidence supports beta-cell necrosis as the primary mechanism by which IL-1 induces beta-cell death, and that this death pathway is mediated, in part, by nitric oxide.
###end p 84
###begin p 85
###xml 197 199 191 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b047">47</xref>
###xml 200 202 194 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b048">48</xref>
###xml 337 339 324 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b047">47</xref>
###xml 340 342 327 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b048">48</xref>
###xml 570 572 553 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b047">47</xref>
###xml 573 575 556 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b064">64</xref>
###xml 794 796 773 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b014">14</xref>
###xml 1147 1149 1116 1118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b019">19</xref>
###xml 1150 1152 1119 1121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b048">48</xref>
###xml 1276 1278 1245 1247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b065">65</xref>
###xml 1810 1812 1776 1778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b066">66</xref>
###xml 2276 2285 2238 2247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030017-g010">Figure 10</xref>
###xml 2913 2915 2872 2874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b067">67</xref>
###xml 2916 2918 2875 2877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b069">69</xref>
###xml 76 79 <span type="species:ncbi:10116">rat</span>
###xml 179 184 <span type="species:ncbi:9606">human</span>
###xml 283 288 <span type="species:ncbi:9606">human</span>
###xml 358 363 <span type="species:ncbi:9606">human</span>
###xml 900 905 <span type="species:ncbi:9606">human</span>
###xml 990 995 <span type="species:ncbi:9606">human</span>
###xml 1204 1209 <span type="species:ncbi:9606">human</span>
###xml 1437 1442 <span type="species:ncbi:9606">human</span>
###xml 1515 1520 <span type="species:ncbi:9606">human</span>
###xml 1628 1631 <span type="species:ncbi:10116">rat</span>
###xml 1635 1640 <span type="species:ncbi:10090">mouse</span>
###xml 1797 1800 <span type="species:ncbi:10116">rat</span>
###xml 2086 2091 <span type="species:ncbi:9606">human</span>
###xml 2188 2193 <span type="species:ncbi:9606">human</span>
###xml 2336 2341 <span type="species:ncbi:9606">human</span>
###xml 2561 2566 <span type="species:ncbi:9606">human</span>
###xml 2794 2797 <span type="species:ncbi:10116">rat</span>
###xml 2978 2983 <span type="species:ncbi:9606">human</span>
###xml 3118 3123 <span type="species:ncbi:9606">human</span>
While IL-1 is sufficient to inhibit the function and to induce the death of rat beta-cells, alone, the exogenous addition of IL-1 does not inhibit the function or induce death of human beta-cells [47,48]. A combination of the cytokines IL-1, TNF, and IFN-gamma is required to impair human beta-cell function and induce islet cell death [47,48]. Treatment of human islets for 24- or 48-h with IL-1 + IFN-gamma + TNF results in inhibition of glucose-stimulated insulin secretion and mitochondrial aconitase activity, effects attenuated by the iNOS inhibitors NMMA and AG [47,64]. In addition, the local release of IL-1 by intraislet macrophages in response to TNF + IFN-gamma + LPS treatment results in inhibition of glucose-stimulated insulin secretion that is attenuated by inhibitors of iNOS [14]. These findings support a role for nitric oxide as a mediator of cytokine-induced beta-cell damage in human following exposures of 24 and 48 h. In contrast, extended incubation (for 6-9 d) of human islets with IL-1 + TNF + IFN-gamma has been reported to inhibit insulin secretion and induce beta-cell apoptosis in a nitric oxide-independent manner [19,48]. The latter findings have led to speculation that human islets are less sensitive to nitric oxide than are rodent islets [65]. Comparisons of cellular responses to cytokines across species are complicated by the genetic background of each species. This is especially true when using human islets in which the genetic background is different for each individual human islet preparation. In contrast, studies with rodent islets are usually performed with a specific strain of rat or mouse. Importantly, Nerup and coworkers have shown that the ability of IL-1 to inhibit beta-cell function and to induce iNOS expression varies in three different rat strains [66]. These findings suggest that the genetic background, even within a given species of animal, contributes to the islet response to cytokines. Taking this into account, we have evaluated the effects of IL-1, TNF, and IFN-gamma on nitric oxide production and HMGB1 release by human islets. In three of five preparations, the combination of cytokines stimulated HMGB1 release by human islets by a mechanism that was sensitive to inhibition by the iNOS inhibitors AG (Figure 10) and NMMA (unpublished data). Importantly, in two human islet preparations the combination of cytokines failed to stimulate HMGB1 release and also failed to stimulate nitric oxide production or iNOS expression. The reason for this lack of response to cytokines in two of the human islet preparations is unknown; however, it has been reported that elevated levels of heat-shock protein 70 attenuate the ability of beta-cells to express iNOS and produce nitric oxide, and the strain differences in response of rat islets to IL-1 have been reported to be associated with differences in levels of heat-shock protein 70 expression [67-69]. Taking this into account, our findings suggest that when human islets produce sufficient levels of nitric oxide in response to cytokines, one consequence is the release of HMGB1. In contrast, when human islets fail to respond to cytokines by producing nitric oxide, they also do not release HMGB1.
###end p 85
###begin p 86
###xml 216 218 212 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b070">70</xref>
###xml 219 221 215 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b072">72</xref>
###xml 303 305 299 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b073">73</xref>
###xml 466 468 462 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b074">74</xref>
###xml 469 471 465 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b076">76</xref>
###xml 716 718 712 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b077">77</xref>
###xml 845 847 841 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b077">77</xref>
###xml 1376 1378 1369 1371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b013">13</xref>
###xml 1379 1381 1372 1374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b014">14</xref>
###xml 1382 1384 1375 1377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030017-b078">78</xref>
HMGB1 is not only a marker of cells undergoing necrosis, but it is also immunologically active. It has been shown to bind to Toll2 and Toll4 receptors and to activate nuclear factor kappaB-dependent gene expression [70-72], and antagonists of HMGB1 have been shown to attenuate sepsis in animal models [73]. It is well established that necrotic cells release immunological adjuvants that activate APCs and that amplify and sustain T cell-dependent immune responses [74-76]. Recently, Rovere-Querini et al. showed that necrotic HMGB1-deficient cells have a reduced capacity to activate APCs, and that HMGB1 neutralization attenuates the ability of supernatants derived from necrotic wild-type cells to activate APCs [77]. HMGB1 also appears to enhance primary antibody responses to soluble antigens and to enhance cytotoxic lymphocyte responses [77]. While caution should be exercised when extrapolating in vitro findings to mechanisms of disease pathogenesis, it is tempting to speculate on the potential role of intraislet macrophage activation as a precipitating event in the development of autoimmune diabetes. In previous studies, we have shown that the 10-15 resident macrophages found in islets, when activated, produce IL-1 to levels sufficient to inhibit beta-cell function in a manner similar to that occurring with the exogenous addition of this cytokine to islets [13,14,78]. We now show that, at these same concentrations, IL-1 kills beta-cells by necrotic mechanisms that are associated with the release of the immunological adjuvant HMGB1-a molecule known to augment APC activation and cytolytic responses of T cells.
###end p 86
###begin p 87
We would like to thank Colleen Bratcher for expert technical assistance. National Institutes of Health Grant DK 52194 and DK 68839 (JAC) and predoctoral fellowship awards from the American Heart Association (SAS and KTC) supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 87
###begin title 88
References
###end title 88
###begin article-title 89
Pathologic anatomy of the pancreas in juvenile diabetes mellitus
###end article-title 89
###begin article-title 90
Insulin-dependent diabetes mellitus as an autoimmune disease
###end article-title 90
###begin article-title 91
Beta-cell death during progression to diabetes
###end article-title 91
###begin article-title 92
The role of interleukin-1 in the pathogenesis of IDDM
###end article-title 92
###begin article-title 93
Cytokines and their roles in pancreatic islet beta-cell destruction and insulin-dependent diabetes mellitus
###end article-title 93
###begin article-title 94
###xml 15 20 <span type="species:ncbi:9606">human</span>
Measurement of human IL-1 by LIF induction, pancreatic islet-cell cytotoxicity, and bone resorption
###end article-title 94
###begin article-title 95
Cytokines cause functional and structural damage to isolated islets of Langerhans
###end article-title 95
###begin article-title 96
The harmony of the spheres: Inducible nitric oxide synthase and related genes in pancreatic beta cells
###end article-title 96
###begin article-title 97
Cytotoxic role of nitric oxide in diabetes
###end article-title 97
###begin article-title 98
Targeted overactivity of beta cell K(ATP) channels induces profound neonatal diabetes
###end article-title 98
###begin article-title 99
###xml 52 57 <span type="species:ncbi:9606">human</span>
Electrophysiology of stimulus-secretion coupling in human beta-cells
###end article-title 99
###begin article-title 100
Interleukin 1 beta induces the formation of nitric oxide by beta-cells purified from rodent islets of Langerhans. Evidence for the beta-cell as a source and site of action of nitric oxide
###end article-title 100
###begin article-title 101
Intraislet release of interleukin 1 inhibits beta cell function by inducing beta cell expression of inducible nitric oxide synthase
###end article-title 101
###begin article-title 102
###xml 47 52 <span type="species:ncbi:9606">human</span>
IL-1 produced and released endogenously within human islets inhibits beta cell function
###end article-title 102
###begin article-title 103
Interleukin-1 plus gamma-interferon-induced pancreatic beta-cell dysfunction is mediated by beta-cell nitric oxide production
###end article-title 103
###begin article-title 104
###xml 52 57 <span type="species:ncbi:10090">mouse</span>
Cytokine-induced inhibition of insulin release from mouse pancreatic beta-cells deficient in inducible nitric oxide synthase
###end article-title 104
###begin article-title 105
###xml 0 15 <span type="species:ncbi:10090">Transgenic mice</span>
Transgenic mice overexpressing type 2 nitric-oxide synthase in pancreatic beta cells develop insulin-dependent diabetes without insulitis
###end article-title 105
###begin article-title 106
Beta-cell apoptosis: Stimuli and signaling
###end article-title 106
###begin article-title 107
A choice of death-The signal-transduction of immune-mediated beta-cell apoptosis
###end article-title 107
###begin article-title 108
Beta-cell apoptosis and defense mechanisms: Lessons from type 1 diabetes
###end article-title 108
###begin article-title 109
Inactivation of the poly(ADP-ribose) polymerase gene affects oxygen radical and nitric oxide toxicity in islet cells
###end article-title 109
###begin article-title 110
###xml 120 123 120 123 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;/&#8211;</sup>
###xml 55 59 <span type="species:ncbi:10090">mice</span>
Cytokines induce apoptosis in beta-cells isolated from mice lacking the inducible isoform of nitric oxide synthase (iNOS-/-)
###end article-title 110
###begin article-title 111
The role of cytokines as effectors of tissue destruction in autoimmunity
###end article-title 111
###begin article-title 112
Caspases: Enemies within
###end article-title 112
###begin article-title 113
The machinery of programmed cell death
###end article-title 113
###begin article-title 114
Alkylating DNA damage stimulates a regulated form of necrotic cell death
###end article-title 114
###begin article-title 115
Isolation of islets of Langerhans from rodent pancreas
###end article-title 115
###begin article-title 116
Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
###end article-title 116
###begin article-title 117
Toxicity determined in vitro by morphological alterations and neutral red absorption
###end article-title 117
###begin article-title 118
Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages
###end article-title 118
###begin article-title 119
Mechanisms of beta-cell death in response to double-stranded (ds) RNA and interferon-gamma: dsRNA-dependent protein kinase apoptosis and nitric oxide-dependent necrosis
###end article-title 119
###begin article-title 120
Interferon-gamma increases the sensitivity of islets of Langerhans for inducible nitric-oxide synthase expression induced by interleukin 1
###end article-title 120
###begin article-title 121
Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids
###end article-title 121
###begin article-title 122
###xml 76 79 <span type="species:ncbi:10116">rat</span>
Role of p38 mitogen-activated protein kinase (p38 MAPK) in cytokine-induced rat islet cell apoptosis
###end article-title 122
###begin article-title 123
Apoptotic signal transduction pathways in diabetes
###end article-title 123
###begin article-title 124
Selection of insulinoma cell lines with resistance to interleukin-1beta- and gamma-interferon-induced cytotoxicity
###end article-title 124
###begin article-title 125
Induction of neuronal apoptosis by camptothecin, an inhibitor of DNA topoisomerase-I: Evidence for cell cycle-independent toxicity
###end article-title 125
###begin article-title 126
Induction of a common pathway of apoptosis by staurosporine
###end article-title 126
###begin article-title 127
Apoptotic signal transduction: Emerging pathways
###end article-title 127
###begin article-title 128
Mechanisms of caspase activation
###end article-title 128
###begin article-title 129
Nitric oxide inhibits caspase-3 by S-nitrosation in vivo
###end article-title 129
###begin article-title 130
Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms
###end article-title 130
###begin article-title 131
Nitric oxide reversibly inhibits seven members of the caspase family via S-nitrosylation
###end article-title 131
###begin article-title 132
###xml 117 120 <span type="species:ncbi:10116">rat</span>
The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells
###end article-title 132
###begin article-title 133
New EMBO members' review: Rhe double life of HMGB1 chromatin protein: Architectural factor and extracellular signal
###end article-title 133
###begin article-title 134
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
###end article-title 134
###begin article-title 135
###xml 74 79 <span type="species:ncbi:9606">human</span>
Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans
###end article-title 135
###begin article-title 136
###xml 19 24 <span type="species:ncbi:9606">human</span>
Cytokines suppress human islet function irrespective of their effects on nitric oxide generation
###end article-title 136
###begin article-title 137
###xml 23 28 <span type="species:ncbi:9606">human</span>
###xml 33 36 <span type="species:ncbi:10116">rat</span>
###xml 58 63 <span type="species:ncbi:9606">human</span>
Species differences in human and rat islet sensitivity to human cytokines. Monoclonal anti-interleukin-1 (IL-1) influences on direct and indirect IL-1-mediated islet effects
###end article-title 137
###begin article-title 138
###xml 3 4 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 12 13 12 13 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 92 97 <span type="species:ncbi:10090">mouse</span>
CD4+ and CD8+ T lymphocytes: Clarification of their pathogenic roles in diabetes in the NOD mouse
###end article-title 138
###begin article-title 139
Physiological beta cell death triggers priming of self-reactive T cells by dendritic cells in a type-1 diabetes model
###end article-title 139
###begin article-title 140
The induction of tolerance by dendritic cells that have captured apoptotic cells
###end article-title 140
###begin article-title 141
North-American twins with IDDM. Genetic, etiological, and clinical significance of disease concordance according to age, zygosity, and the interval after diagnosis in first twin
###end article-title 141
###begin article-title 142
Diabetes in identical twins. A study of 200 pairs
###end article-title 142
###begin article-title 143
The intraislet macrophage and type I diabetes
###end article-title 143
###begin article-title 144
Activation of intraislet lymphoid cells causes destruction of islet cells
###end article-title 144
###begin article-title 145
Cytokines and nitric oxide in islet inflammation and diabetes
###end article-title 145
###begin article-title 146
Essential fatty acid depletion of renal allografts and prevention of rejection
###end article-title 146
###begin article-title 147
###xml 41 44 <span type="species:ncbi:10116">rat</span>
Essential fatty acid deficiency depletes rat glomeruli of resident macrophages and inhibits angiotensin II-induced eicosanoid synthesis
###end article-title 147
###begin article-title 148
###xml 99 103 <span type="species:ncbi:10090">mice</span>
Essential fatty acid deficiency prevents multiple low-dose streptozotocin-induced diabetes in CD-1 mice
###end article-title 148
###begin article-title 149
###xml 33 36 <span type="species:ncbi:10116">rat</span>
Prevention of diabetes in the BB rat by essential fatty acid deficiency. Relationship between physiological and biochemical changes
###end article-title 149
###begin article-title 150
Pancreatic beta-cell damage mediated by beta-cell production of interleukin-1. A novel mechanism for virus-induced diabetes
###end article-title 150
###begin article-title 151
Chromatin and cell death
###end article-title 151
###begin article-title 152
Irreversible inhibition of metabolic function and islet destruction after a 36-hour exposure to interleukin-1beta
###end article-title 152
###begin article-title 153
###xml 34 40 <span type="species:ncbi:9606">humans</span>
Major species differences between humans and rodents in the susceptibility to pancreatic beta-cell injury
###end article-title 153
###begin article-title 154
###xml 47 50 <span type="species:ncbi:10116">rat</span>
Strain-dependent differences in sensitivity of rat beta-cells to interleukin 1 beta in vitro and in vivo: Association with islet nitric oxide synthesis
###end article-title 154
###begin article-title 155
Heat shock protein hsp70 overexpression confers resistance against nitric oxide
###end article-title 155
###begin article-title 156
###xml 73 76 <span type="species:ncbi:10116">rat</span>
###xml 81 86 <span type="species:ncbi:9606">human</span>
Heat shock inhibits cytokine-induced nitric oxide synthase expression by rat and human islets
###end article-title 156
###begin article-title 157
###xml 85 88 <span type="species:ncbi:10116">rat</span>
Strain-dependent difference in inducible nitric oxide synthesis (iNOS) expression in rat pancreatic islets correlates with interferon regulating factor 1 (IRF-1) and heat shock protein 70 (HSP70) expression
###end article-title 157
###begin article-title 158
###xml 89 94 89 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="boxed-text" rid="pmed-0030017-box001">box 1</xref>
Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein
###end article-title 158
###begin article-title 159
###xml 14 19 <span type="species:ncbi:9606">human</span>
Activation of human neonatal monocyte-derived dendritic cells by lipopolysaccharide down-regulates birch allergen-induced Th2 differentiation
###end article-title 159
###begin article-title 160
RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages
###end article-title 160
###begin article-title 161
###xml 80 85 80 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="boxed-text" rid="pmed-0030017-box001">box 1</xref>
Reversing established sepsis with antagonists of endogenous high-mobility group box 1
###end article-title 161
###begin article-title 162
Major histocompatibility complex class I-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction
###end article-title 162
###begin article-title 163
Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway
###end article-title 163
###begin article-title 164
Hsp70 promotes antigen-presenting cell function and converts T-cell tolerance to autoimmunity in vivo
###end article-title 164
###begin article-title 165
HMGB1 is an endogenous immune adjuvant released by necrotic cells
###end article-title 165
###begin article-title 166
Potential role of resident islet macrophage activation in the initiation of autoimmune diabetes
###end article-title 166
###begin title 167
Abbreviations
###end title 167
###begin p 168
aminoguanidine
###end p 168
###begin p 169
antigen-presenting cell
###end p 169
###begin p 170
4',6-diamidino-2-phenylindole dihydrochloride
###end p 170
###begin p 171
###xml 13 16 13 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N,N</italic>
sodium (Z)-1(N,N-diethylamino) diazen-1-ium-1,2-diolate
###end p 171
###begin p 172
###xml 20 25 20 25 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="boxed-text" rid="pmed-0030017-box001">box 1</xref>
high-mobility group box 1 protein
###end p 172
###begin p 173
interferon
###end p 173
###begin p 174
interleukin
###end p 174
###begin p 175
inducible nitric oxide synthase
###end p 175
###begin p 176
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide
###end p 176
###begin p 177
###xml 1 2 1 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</sup>
NG-monomethyl-L-arginine
###end p 177
###begin p 178
phosphatidylserine
###end p 178
###begin p 179
standard error of the mean
###end p 179
###begin p 180
tumor necrosis factor
###end p 180
###begin p 181
terminal nick-end labeling
###end p 181
###begin title 182
Figures and Tables
###end title 182
###begin title 183
Nitric Oxide Mediates IL-1-Induced beta-Cell Death as Determined by the MTT Assay
###end title 183
###begin p 184
###xml 26 29 <span type="species:ncbi:10116">rat</span>
RINm5F cells (A and B) or rat islets (C and D) were treated with IL-1 (10 units/ml) and NMMA (2 mM) for either 24 or 48 h, as indicated. The cells were isolated and viability determined using the MTT assay (A and C). The culture supernatants were isolated and nitrite production was determined using the Griess assay (B and D).
###end p 184
###begin p 185
###xml 226 229 <span type="species:ncbi:10116">rat</span>
(E and F) The effects of exogenously produced nitric oxide supplied by the donor compound DEANO (500 muM) and the apoptosis inducer camptothecin (25 muM) on RINm5F cell viability (E) and the apoptosis inducer staurosporine on rat islet cell viability (F) were determined by MTT assay.
###end p 185
###begin p 186
###xml 189 190 187 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 250 251 248 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Cell viability data is expressed as percent death. Results for cell viability and nitrite production are the average +/- standard error of the mean (SEM) of three independent experiments. *p < 0.05, significantly different from untreated controls. **p < 0.05, significantly different from IL-1-treated condition.
###end p 186
###begin title 187
Effects of IL-1 on beta-Cell Viability as Determined by Neutral Red Uptake
###end title 187
###begin p 188
###xml 277 278 274 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 338 339 335 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
RINm5F cells were treated for 24 h or 48 h with IL-1 (10 units/ml), NMMA (2 mM) (A), or camptothecin (25 muM) (B), and the cells were isolated and percentage of death determined using the neutral red uptake assay. Results are average +/- SEM of three independent experiments. *p < 0.05, significantly different from untreated controls. **p < 0.05, significantly different from IL-1-treated condition.
###end p 188
###begin title 189
Morphological Analysis of IL-1-Induced RINm5F Cell Death
###end title 189
###begin p 190
RINm5F cells were treated for 24 h with IL-1 (10 units/ml) (B and C), NMMA (2 mM) (C), or camptothecin (25 muM) (D), and cellular morphology was examined by phase-contrast microscopy. Treatment with IL-1 resulted in cell swelling and detachment (B), events that are prevented by NMMA (C). In contrast to the effects of IL-1, induction of apoptosis using camptothecin (D) resulted in cell shrinkage and condensation of the nucleus. Untreated control cells are shown in (A). Results are representative of three independent experiments.
###end p 190
###begin title 191
IL-1 Stimulates RINm5F Cell DNA Damage in a Nitric Oxide-Dependent Manner
###end title 191
###begin p 192
Treatment of RINm5F cells for 24 h (B) or 48 h (C) with IL-1 (10 units/ml) resulted in DNA damage, as determined by TUNEL staining (green fluorescence). DNA damage was attenuated by NMMA (E and F). The apoptosis inducer camptothecin (25 muM) stimulated DNA damage (D), and this DNA damage is morphologically distinct from that induced by IL-1. Nuclei are stained with DAPI (blue). The morphological differences in TUNEL staining, the loss of nuclear membrane integrity in response to IL-1 (B and C) and the condensation of DNA in response to camptothecin (D) are highlighted using white arrows. The levels of DNA damage in control cells (A) were less than 5%. Results are representative of three independent experiments.
###end p 192
###begin title 193
IL-1 Stimulates Islet Cell DNA Damage in a Nitric Oxide-Dependent Manner
###end title 193
###begin p 194
###xml 13 16 <span type="species:ncbi:10116">rat</span>
Treatment of rat islet cells for 24 h with IL-1 resulted in DNA damage as determined by TUNEL staining, and approximately95% of this damage occurred in insulin-containing cells (red fluorescence) (B). Nitric oxide appears to mediate IL-1-induced DNA damage, as it was attenuated by the NOS inhibitor NMMA (2 mM) (D). The apoptosis inducer staurosporine (1 muM) also stimulated DNA damage in both insulin containing and non-insulin containing cells (C). Less than 10% of control, untreated islet cells were TUNEL-positive (A). Results are representative of three independent experiments.
###end p 194
###begin title 195
###xml 52 55 <span type="species:ncbi:10116">Rat</span>
IL-1 Fails to Activate Caspase-3 in RINm5F Cells or Rat Islets
###end title 195
###begin p 196
(A) IL-1 (10 units/ml), alone or in combination with NMMA (2 mM) and the nitric oxide donor DEANO (500 muM), failed to activate caspase-3 in RINm5F cells following a 24- or 48-h exposure. As a positive control, the apoptosis inducer camptothecin (25 muM) stimulated a 9-fold increase in RINm5F cell caspase-3 activity.
###end p 196
###begin p 197
###xml 341 342 338 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 32 35 <span type="species:ncbi:10116">rat</span>
###xml 244 247 <span type="species:ncbi:10116">rat</span>
(B) Similar to RINm5F cells, in rat islets IL-1 (10 units/ml) alone or in combination with NMMA (2 mM) failed to activate caspase-3 following a 24- or 48-h incubation. The apoptosis inducer staurosporine (1 muM) stimulated a 5-fold increase in rat islet caspase-3 activity. Results are the average +/- SEM of three independent experiments. *p < 0.05, significantly different from untreated control.
###end p 197
###begin title 198
###xml 58 61 <span type="species:ncbi:10116">Rat</span>
Effects of IL-1 on Annexin V Staining in RINm5F Cells and Rat Islets
###end title 198
###begin p 199
###xml 574 575 558 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 33 36 <span type="species:ncbi:10116">rat</span>
###xml 256 259 <span type="species:ncbi:10116">rat</span>
###xml 495 498 <span type="species:ncbi:10116">rat</span>
Treatment of RINm5F cells (A) or rat islet cells (B) with 10 units/ml IL-1 did not stimulate PS externalization, as determined by annexin V staining and quantified by flow cytometry. In contrast, treatment of RINm5F Cells with camptothecin (25 muM) (A) or rat islet cells with staurosporine (1 muM) (B) stimulated the externalization of PS. Results are presented as percent increase in annexin V-positive cells above the basal levels (approximately3%-7%) detected on untreated control RINm5F or rat islet cells and are the average +/- SEM of three independent experiments. *p < 0.05, significantly different from untreated control.
###end p 199
###begin title 200
###xml 50 53 <span type="species:ncbi:10116">Rat</span>
IL-1 Stimulates HMGB1 Release in RINm5F Cells and Rat Islets
###end title 200
###begin p 201
###xml 30 33 <span type="species:ncbi:10116">rat</span>
###xml 330 333 <span type="species:ncbi:10116">rat</span>
(A and B) RINm5F cells (A) or rat islets (B) were treated for 24 or 48 h with 10 units/ml of IL-1 and 2 mM NMMA as indicated. The levels of HMGB1 released into the supernatant (s) and contained in the cells (p) were determined by Western blot analysis. Results show that IL-1 stimulates the release of HMGB1 from RINm5F cells and rat islets, and that this release is attenuated by the NOS inhibitor NMMA.
###end p 201
###begin p 202
(C) Treatment of RINm5F cells for 24 h with DEANO (500 muM) stimulated HMGB1 release, while the apoptosis inducer camptothecin (25 muM) failed to stimulate HMGB1 release from RINm5F cells.
###end p 202
###begin p 203
###xml 106 109 <span type="species:ncbi:10116">rat</span>
(D) Nitric oxide supplied exogenously via treatment with DEANO (500 muM) also stimulated HMGB1 release by rat islets, while HMGB1 was not released under conditions of beta-cell apoptosis in response to treatment with staurosporine. Results are representative of three independent experiments.
###end p 203
###begin title 204
Caspase-3 Inhibition Prevents beta-Cell Apoptosis but Does Not Prevent IL-1-Induced Necrosis
###end title 204
###begin p 205
###xml 719 720 715 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 779 780 775 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
The caspase-3 inhibitor Z-DQMD-CHO (100 muM) attenuated RINm5F cell death induced by a 24-h incubation with camptothecin as determined by MTT assay (A) or annexin V staining (B). This caspase-3 inhibitor failed to prevent RINm5F cell death in response to a 48-h incubation with 10 units/ml IL-1 as determined by the MTT assay (C). Z-DQMD-CHO also did not attenuate HMGB1 release by RINm5F cells treated for 24 h with 500 muM DEANO (D) or for 48 h with 10 units/ml IL-1 (E). The levels of HMGB1 released into the supernatant (s) and contained in the cells (p) were determined by Western blot analysis. Results for MTT assay (A and B) and annexin V staining (C) are the average +/- SEM of three independent experiments. *p < 0.05, significantly different from untreated control. **p < 0.05, significantly different from camptothecin-treated condition. Results for HMGB1 release are representative of three independent experiments.
###end p 205
###begin title 206
###xml 62 67 <span type="species:ncbi:9606">Human</span>
Nitric Oxide-Dependent Release of HMGB1 from Cytokine-Treated Human Islets
###end title 206
###begin p 207
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human islets (200 islets in 400 mul of complete CMRL-1066) were treated with a combination of IL-1 (50 units/ml), IFN-gamma (500 units/ml), and TNF (50 nM) in the presence or absence of the NOS inhibitor AG (2 mM) or treated with staurosporine (1 muM) alone.
###end p 207
###begin p 208
(A) Following 48h -incubation the supernatant was removed and nitrite production was determined using the Griess assay. The levels of HMGB1 released into the supernatant (s) and contained in the islets (p) were determined by Western blot analysis.
###end p 208
###begin p 209
###xml 187 192 <span type="species:ncbi:9606">human</span>
###xml 281 286 <span type="species:ncbi:9606">human</span>
(B) Results indicate that cytokine-stimulated HMGB1 release correlates with nitric oxide production, and that inhibition of nitric oxide production using AG attenuates HMGB1 release from human islets. Similar results have been obtained in three of five independent preparations of human islets.
###end p 209
###begin p 210
Citation: Steer SA, Scarim AL, Chambers KT, Corbett JA (2006) Interleukin-1 stimulates beta-cell necrosis and release of the immunological adjuvant HMGB1. PLoS Med 3(2): e17.
###end p 210

